Capecitabine 500mg Tablets

Capecitabine 500mg Tablets

Product Details:


Product Description

With antineoplastic activity, Capecitabine is a fluoropyrimidine carbamate. It is an orally directed systemic prodrug of 5'-deoxy-5-fluorouridine (5'-DFUR) that is transformed to 5-fluorouracil. 5'-deoxy-5-fluoro-N-[(pentyloxy) carbonyl]-cytidine is the chemical name for capecitabine. It is a cancer medication that inhibits the development of cancer cells and reduces their spread in the body. It is used to treat colon or rectum cancer and breast cancer that has blowout to other portions of the body. It is often used in combination with other cancer medications and/or radiation treatments.

It is manufactured by various Indian manufacturers.

Additional Information :

  • You should not take this medicine if you are sensitive to fluorouracil (Adrucil) or capecitabine, or if you have serious kidney illness or a metabolic illness known as DPD (dihydropyrimidine dehydrogenase) shortage.
  • Prior to you take capecitabine, inform your healthcare practitioner if you have kidney or liver disease, a past of coronary artery disease, or if you are consuming folic acid (comprised in numerous vitamin and mineral supplements), phenytoin (Dilantin), leucovorin (Wellcovorin), or a blood thinner (Coumadin, warfarin).

Side Effects:

Call your healthcare practitioner at once if you have a severe side effect like:
  • Nausea, eating much less than usual, loss of appetite, vomiting (greater than once in 24 hours)
  • Serious diarrhea (greater than 4 times per day, or thru the night)
  • Black, bloody, or tarry stools
  • Coughing up of blood or vomit that appears like coffee grounds
  • Chills, body aches, fever, easy bruising, flu Indications


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

"We mainly export our products to the foreign countries."
Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.